Yüklüyor......
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study
This post hoc analysis assessed the effects on cardiovascular risk factors of body weight, systolic blood pressure (SBP) and triglycerides after 28 weeks’ treatment with exenatide once weekly plus dapagliflozin, as compared with exenatide once weekly or dapagliflozin, in patient subpopulations from...
Kaydedildi:
| Yayımlandı: | Diabetes Obes Metab |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Blackwell Publishing Ltd
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5969082/ https://ncbi.nlm.nih.gov/pubmed/29316164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13206 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|